Regarding the individual outcome of MACEs, circulating RBP4 level was significantly associated with HF rather than cardiovascular death, which was different from a prior study that reported that total RBP4 level was a predictor of cardiac death in patients with stable CAD or acute coronary syndrome (9). This evidence concerns the gene RBP4 and acute coronary syndrome.